Cremaschi G A, Sterin-Borda L
Cefaprin (CONICET), Buenos Aires, Argentina.
Int J Immunopharmacol. 1988;10(5):569-78. doi: 10.1016/0192-0561(88)90075-6.
It has been previously demonstrated that murine alloimmune IgG, while specifically recognizing class I histocompatibility (HC) antigens (Ag) of cardiac tissue, was able to increase the contractile tension and frequency of spontaneously beating isolated preparations and that this effect involved beta adrenoceptor activation. Here we show that beta 1 adrenoceptors of murine myocardium are the only stimulatory cardiac receptors that could interact with alloantibodies (allo-Ab), as the specific blockade of stimulant receptors did not alter alloimmune IgG mechanical effect on atria. Moreover, beta adrenergic participation in the phenomenon was confirmed by the isoproterenol-like increase of cardiac cAMP levels in cardiac preparations pre-treated with allo-Ab, that could be blocked by the beta antagonist propranolol. We also show that alloimmune IgG fixation to myocardium could be specifically interfered with by beta- and beta 1-selective blockers. All these data point to the fact that the mechanism whereby alloimmune IgG may trigger a beta adrenergic biological effect is through a direct molecular interaction between HC Ag and adenylate cyclase-coupled beta adrenoceptors.
先前已经证明,小鼠同种免疫IgG虽然能特异性识别心脏组织的I类组织相容性(HC)抗原(Ag),但能够增加离体自发搏动标本的收缩张力和频率,且这种效应涉及β肾上腺素能受体激活。在此我们表明,小鼠心肌的β1肾上腺素能受体是唯一能与同种抗体(allo-Ab)相互作用的刺激性心脏受体,因为刺激性受体的特异性阻断并未改变同种免疫IgG对心房的机械效应。此外,在用allo-Ab预处理的心脏标本中,心脏cAMP水平出现异丙肾上腺素样升高,这证实了β肾上腺素能参与了该现象,而这种升高可被β拮抗剂普萘洛尔阻断。我们还表明,β和β1选择性阻滞剂可特异性干扰同种免疫IgG与心肌的结合。所有这些数据表明,同种免疫IgG触发β肾上腺素能生物学效应的机制是通过HC Ag与腺苷酸环化酶偶联的β肾上腺素能受体之间的直接分子相互作用。